3
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Current issues in transfusion therapy

1. Risks of infection

Pages 219-224 | Published online: 16 May 2016

References

  • Widmann FK, ed. AABB technical manual. 9th ed. Arlington. VA: Am Assoc of Blood Banks. 1985
  • Centers for Disease Control. Transfusion malaria: serologic identification of infected donors: Pennsylvania. Georgia. MMWR 1983: 32(17): 222–9
  • Mollison PL. Blood transfusion in clinical medicine. 7th ed. Boston: Blackwell Scientific Publications. 1983
  • Braine HG, Kickler TS, Charache P. et al. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 1986: 26(4): 391–3
  • Heal JM, Singal S, Sardisco E, et al. Bacterial proliferation in platelet concentrates. Transfusion 1986: 26(4): 388–90
  • Polesky HF, Hanson M. Transfusion-associated hepatitis: a dilemma. Lab Med 1983: 14(11): 717–20
  • Roeckel IE, Watts WT. Prevalence of post-transfusion non-A. non-B hepatitis. Pathologist 1986: 40(7): 6–7
  • Wick MR. Moore S, Taswell HF. Non-A. non-B hepatitis associated with blood transfusion. Transfusion 1985: 25(2): 93–101
  • Hoofnagle JH. Type A and type B hepatitis. Lab Med 1983: 14(11): 705–16
  • Buchner BK, Moore BP. Prevalence of delta agent among Canadian blood donors. (Letter) Transfusion 1986: 26(4): 400
  • Rosina F. Saracco G, Rizzetto M. Risk of post-transfusion infection with the hepatitis delta virus: a multicenter study. N Engl J Med 1985: 312(23): 1488–91
  • Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A. non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med 1981: 304(17): 989–94
  • Sampliner RE, Beluk D, Harrow EJ, et al. The persistence and significance of elevated alanine aminotransferase levels in blood donors. Transfusion 1985: 25(2): 102–4
  • Koziol DE, Holland PV, Alling DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986: 104(4): 488–95
  • Yeager AS, Grumet FC, Hafleigh EB, et al. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981: 98(2): 281–7
  • Demmler GJ, Brady MT, Bijou H, et al. Post-transfusion cytomegalovirus infection in neonates: role of saline-washed red blood cells. J Pediatr 1986: 108(5 Pt 1): 762–5
  • Bove JR. The response to AIDS. (Editorial) Transfusion 1985: 25(1): 1–2
  • Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associatedvirus infections. MMWR 1986: 35(20): 334–9
  • Peterman TA, Jaffe HW, Feorino PM, et al. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA 1985: 254(20): 2913–7
  • Jaffe HW, Sarngadharan MG, DeVico AL, et al. Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome: serologic evidence of an association. JAMA 1985: 254(6): 770–3
  • Feorino PM, Jaffe HW, Palmer E, et al. Transfusion-associated acquired immunodeficiency syndrome: evidence for persistent infection in blood donors. N Engl J Med 1985: 312(20): 1293–6
  • Pindyck J, Waldman A, Zang E, et al. Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion: evidence of volunteer blood donor cooperation. Transfusion 1985: 25(1): 3–9
  • Centers for Disease Control. Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor: Colorado. JAMA 1986: 256(5): 574–5
  • Grindon AJ. Efficacy of voluntary self-deferral of donors at high risk of AIDS. (Abstr) Transfusion 1984: 24: 434
  • Kolins J. The continued risk of transfusion-transmitted AIDS. Pathologist 1986: 40(6): 9–10
  • Ward JW, Grindon AJ, Feorino PM, et al. Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III. JAMA 1986: 256(3): 357–61
  • Corran JW, Morgan WM, Hardy AM, et al. The epidemiology of AIDS: current status and future prospects. Science 1985: 229(4720): 1352–7
  • Department of Health and Human Services. Safety of immune globulins in relation to HTLV-IIII. FDA Drug Bull 1986: 16(1): 3
  • Francis DP, Feorino PM, McDongal S, et al. The safety of hepatitis B vaccine: inactivation of the AIDS virus during routine vaccine manufacture. JAMA 1986: 256(7): 869–72
  • Iwarson S, Steen Y, Rybo G, et al. Does Cohn-fractionated Rh immune globulin transmit viral hepatitis? Transfusion 1985: 25(1): 15–7
  • Department of Health and Human Services. Safety of hepatitis B vaccine confirmed. FDA Drug Bull 1985: 15(2): 14–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.